Sign In
Buy ARKG
$33.15
-0.260 (-0.778%)
At Close: Jun 08, 2026
5 ETF Areas That Spooked Investors in October
03:02pm, Monday, 30'th Oct 2023
After a downbeat September, October too remained volatile for Wall Street due to higher rates.
Why Wall Street Thinks This Artificial Intelligence (AI) Stock Could Skyrocket 140% Over the Next 12 Months
05:50am, Monday, 16'th Oct 2023
This company uses AI to improve drug discovery for all of the 20 biggest biopharmaceutical companies. Even the most pessimistic analyst thinks the stock could jump nearly 32% over the next 12 months.
Uranium prices are still ‘nowhere near the peak of the last cycle': Here's why nuclear energy ETFs could power your portfolio
04:22pm, Thursday, 21'st Sep 2023
Hello! This is MarketWatch reporter Isabel Wang bringing you this week's ETF Wrap. In this week's edition, we look at ETFs in the nuclear energy sector, which has emerged as one of the best performing
Best Healthcare ETFs to Buy Now
03:53pm, Thursday, 24'th Aug 2023
The best healthcare ETFs patch investors into an area of the market that offers both defensive properties and long-term growth.
3 Top Growth ETFs to Buy Right Now
08:45am, Monday, 14'th Aug 2023
Growth stocks have rebounded this year after a broad sell-off in 2022. Growth-oriented exchange-traded funds, or ETFs, are an easy and straightforward way to take advantage of this emerging trend.
Cathie Wood Is Buying Up Shares of This Beaten-Down Biotech. Should You?
02:00pm, Thursday, 27'th Jul 2023
Superstar investor Cathie Wood bought shares of Moderna over a period of two days this week. The biotech company may become a respiratory vaccine giant -- with coronavirus, RSV, and flu vaccines -- in
Cathie Wood Says ARK Funds Are Seeing Flows Coming Back
04:57pm, Monday, 17'th Jul 2023
ARK Invest CEO and CIO Cathie Wood comments on ARK's fund flows during an interview with Romaine Bostick and Katie Greifeld on "Bloomberg Markets: The Close."
Does Cathie Wood Have Her Hands on the Next Big Semiconductor Stock?
09:15am, Sunday, 16'th Jul 2023
A recent disclosure shows that Ark Invest has made another substantial investment in Quantum-Si. The young biotech has developed a semiconductor-based protein sequencing platform.
Is Now the Right Time to Embrace Biotech ETFs?
12:34pm, Wednesday, 12'th Jul 2023
Look if it's the right time to invest in biotech ETFs to help diversify your portfolio.
ETF investors are following Warren Buffett and betting big on Japan. But here are key risks to consider.
06:24pm, Thursday, 25'th May 2023
Hello! This is markets reporter Isabel Wang bringing you this week's ETF Wrap. In this week's edition, we take a look at Japan ETFs, which saw significant inflows in the past month after the legendary
ARKG: Smart Idea for Smart Advancements in Cancer Treatment
01:42pm, Monday, 24'th Apr 2023
The cancer treatment/immuno-oncology market is expansive and ripe with potential for long-term healthcare investors. Predictably, there are significant implications for biotechnology and genomics comp
Biotech ETFs' Performance Deserves A Look
03:38pm, Wednesday, 19'th Apr 2023
Biotech comes with a great many positive externalities for society, and can be a big positive for portfolios right now.
ARKG: A Probable Window Of Opportunity, Depending On Banks And The Fed
02:06am, Wednesday, 12'th Apr 2023
Cathie Wood's ARKG provides investors with an opportunity to take advantage of the billion-dollar genomics market. However, it has performed poorly compared to XLV's higher-quality holdings in a perio
Thematic Index Lineup Joins VettaFi and the Future Is Bright
10:01am, Monday, 10'th Apr 2023
A decade ago, when the ROBO Global Robotics & Automation Index ETF (ROBO) launched, the U.S. thematic ETF market was nascent, with only a handful of products and minimal assets. However, at the end of
This Stock Could Propel Genomics ETFs
11:03am, Monday, 03'rd Apr 2023
Under most circumstances, stock picking is difficult, and that difficulty level is ratcheted higher in the disruptive technology space. That's certainly true of genomics investing where fortunes are b
